Discussion on LYNPARZA


6:00 pm - 7:00 pm

Virtual Expert Discussion on LYNPARZA® (olaparib) 

Treatment of mCRPC with LYNPARZA:
An oral therapy for patients with HRR gene mutations following progression on enzalutamide or abiraterone


Presented by:

Kevin Lagman, MBA, MSN, APRN, FNP-C
Advanced Practice Provider, Department of Genitourinary
Medical Oncology
University of Texas MD Anderson Cancer Center
Houston, TX


To register or for more information, contact
Lynn Harris at 626-622-2658 or lynn.harris@astrazeneca.com

About us

The Silicon Valley chapter of the Oncology Nursing Society is committed to provide mechanisms to further the professional development of the individual members within the chapter.

A secondary but equally important mission is to provide an atmosphere of collegial, professional and emotional support to the chapter membership throughout the continued transition in health care as it exists in the state of California and as it evolves throughout the nation..

Contact Info

a 503c Organization, Santa Clara, CA, USA